Merit Medical Systems (NASDAQ: MMSI) is one of 104 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Merit Medical Systems to related businesses based on the strength of its earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.
This table compares Merit Medical Systems and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Merit Medical Systems||3.78%||9.65%||6.02%|
|Merit Medical Systems Competitors||-62.26%||-47.35%||-18.28%|
This is a summary of current recommendations and price targets for Merit Medical Systems and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Merit Medical Systems||0||0||11||0||3.00|
|Merit Medical Systems Competitors||495||1881||3745||115||2.56|
Merit Medical Systems presently has a consensus price target of $48.60, suggesting a potential upside of 8.00%. As a group, “Surgical & medical instruments” companies have a potential upside of 10.96%. Given Merit Medical Systems’ competitors higher possible upside, analysts clearly believe Merit Medical Systems has less favorable growth aspects than its competitors.
Institutional & Insider Ownership
95.3% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 48.0% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 5.0% of Merit Medical Systems shares are owned by company insiders. Comparatively, 16.1% of shares of all “Surgical & medical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Volatility & Risk
Merit Medical Systems has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500. Comparatively, Merit Medical Systems’ competitors have a beta of 0.80, indicating that their average stock price is 20% less volatile than the S&P 500.
Earnings & Valuation
This table compares Merit Medical Systems and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Merit Medical Systems||$727.85 million||$27.52 million||35.16|
|Merit Medical Systems Competitors||$1.54 billion||$111.80 million||-143.19|
Merit Medical Systems’ competitors have higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Merit Medical Systems beats its competitors on 8 of the 13 factors compared.
Merit Medical Systems Company Profile
Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.